| 000 | 04220naa a22005057i 4500 | ||
|---|---|---|---|
| 001 | UMUN-OA-20261005-MLS-051 | ||
| 003 | local | ||
| 005 | 20261005174905.0 | ||
| 006 | m o d | ||
| 007 | cr|||||||||||| | ||
| 008 | 261005s2016 xx o u000 0 eng d | ||
| 024 | 7 |
_a10.1371/journal.pone.0151073 _2doi |
|
| 035 | _a(local)EuropePMC:PMC4783056 | ||
| 040 |
_alocal _beng _clocal |
||
| 041 | 0 | _aeng | |
| 100 | 0 |
_aSamuel G Schumacher _eauthor. |
|
| 245 | 1 | 0 |
_aImpact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study Methodologies. / _cSamuel G Schumacher; Hojoon Sohn; Zhi Zhen Qin [and others]. |
| 264 | 1 |
_a[Place of publication not identified] : _bPLOS, _c2016. |
|
| 300 | _a1 online resource (1 article). | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aPublication type: Review article. | ||
| 500 | _aLinked open-access copy: published version. | ||
| 506 | 0 |
_aOpen access; no subscription required for the linked open-access version. _fUnrestricted online access _2star |
|
| 520 | 3 | _aBackground Several reviews on the accuracy of Tuberculosis (TB) Nucleic Acid Amplification Tests (NAATs) have been performed but the evidence on their impact on patient-important outcomes has not been systematically reviewed. Given the recent increase in research evaluating such outcomes and the growing list of TB NAATs that will reach the market over the coming years, there is a need to bring together the existing evidence on impact, rather than accuracy. We aimed to assess the approaches that have been employed to measure the impact of TB NAATs on patient-important outcomes in adults with possible pulmonary TB and/or drug-resistant TB. Methods We first develop a conceptual framework to clarify through which mechanisms the improved technical performance of a novel TB test may lead to improved patient outcomes and outline which designs may be used to measure them. We then systematically review the literature on studies attempting to assess the impact of molecular TB diagnostics on such outcomes and provide a narrative synthesis of designs used, outcomes assessed and risk of bias across different study designs. Results We found 25 eligible studies that assessed a wide range of outcomes and utilized a variety of experimental and observational study designs. Many potentially strong design options have never been used. We found that much of the available evidence on patient-important outcomes comes from a small number of settings with particular epidemiological and operational context and that confounding, time trends and incomplete outcome data receive insufficient attention. Conclusions A broader range of designs should be considered when designing studies to assess the impact of TB diagnostics on patient outcomes and more attention needs to be paid to the analysis as concerns about confounding and selection bias become relevant in addition to those on measurement that are of greatest concern in accuracy studies. | |
| 540 |
_aCreative Commons Attribution. See the linked licence for the applicable terms. _uhttp://creativecommons.org/licenses/by/4.0/ |
||
| 546 | _aIn English. | ||
| 588 | 0 | _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source. | |
| 590 | _aCourse allocation: B. Sc. Medical Laboratory Science. | ||
| 653 | _aB. Sc. Medical Laboratory Science | ||
| 653 | _aUMUN open access collection | ||
| 653 | _amolecular diagnostics | ||
| 655 | 4 | _aReview articles. | |
| 700 | 0 |
_aHojoon Sohn _eauthor. |
|
| 700 | 0 |
_aZhi Zhen Qin _eauthor. |
|
| 700 | 0 |
_aGenevieve Gore _eauthor. |
|
| 700 | 0 |
_aJ Lucian Davis _eauthor. |
|
| 700 | 0 |
_aClaudia M Denkinger _eauthor. |
|
| 700 | 0 |
_aMadhukar Pai _eauthor. |
|
| 773 | 0 |
_tPloS one _gVol. 11, no. 3, (2016), pages/article e0151073 _x1932-6203 |
|
| 856 | 4 | 0 |
_uhttps://europepmc.org/articles/PMC4783056 _yRead open-access publication _zOpen access. _70 |
| 884 |
_aCourse selection and automated MARC21 enrichment from Europe PMC metadata. _g20261005 _khttps://europepmc.org/articles/PMC4783056 _qlocal |
||
| 942 | _n0 | ||
| 999 |
_c1193 _d1193 |
||